Registered Kenya · PPB

MUCOPAIN

BENZOCAINE USP

H2010/21295/507 BENZOCAINE USP-20.00 %W/W cardiovascular system INN generic

What it does

Benzocaine is a local anesthetic that numbs the skin or mucous membranes to relieve pain or discomfort.

Commonly used for: sore throat, mouth ulcers, toothache, minor burns …

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
H2010/21295/507
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
BENZOCAINE USP
Strength
-
Pack size
-
Therapeutic class
-
ATC class (WHO)
C05AD - Local anesthetics
RxNorm RxCUI
1399
Manufacturer / MAH
Pharma Specialities
Applicant / LTR
-
Country of origin
FOREIGN
Manufacturer location
Panari House, Second Floor, P.O. Box 49146, Nairobi, Kenya

Source: Pharmacy and Poisons Board · fetched 2026-01-28 22:11:59 · updated 2026-03-23 04:57:10

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Benzocaine is a local anesthetic that numbs the skin or mucous membranes to relieve pain or discomfort.

What it treats

  • sore throat
  • mouth ulcers
  • toothache
  • minor burns
  • insect bites

How it works

Benzocaine works by blocking the nerve signals in the area where it is applied, reducing pain and discomfort.

Who it's for

Benzocaine is suitable for adults and children who need relief from localized pain.

Cautions

  • • Do not use if you are allergic to benzocaine or similar products.
  • • Avoid use on large areas of skin or on deep wounds.
  • • Consult a doctor if symptoms persist or worsen.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: benzocaine

BNF-referenced

Benzocaine is a local anesthetic commonly used for its analgesic properties. It is primarily applied topically to relieve pain and discomfort associated with minor skin irritations, sore throat, and dental procedures. Its quick onset and short duration of action make it suitable for various temporary applications.

Indications

  • Topical anesthesia for minor skin irritations
  • Sore throat relief
  • Dental procedures

Dosage

Children: Refer to the BNF for Children for specific dosing recommendations.

Adults: Apply a thin layer to the affected area as needed, not exceeding the recommended frequency in product guidelines.

Mechanism of action

Benzocaine diffuses into nerve cells where it binds to sodium channels, preventing the channels from opening, and blocking the influx of sodium ions. Nerve cells unable to allow sodium into cells cannot depolarize and conduct nerve impulses. Benzocaine reversibly stabilizes the neuronal membrane, decreasing its permeability to sodium ions, thereby inhibiting depolarization of the neuronal membrane and blocking the initiation and conduction of nerve impulses.

Pharmacodynamics

Benzocaine is indicated for use as a topical anesthetic. It has a duration of action of approximately 10 minutes and a wide therapeutic window. Patients should be counselled regarding the risks of methemoglobinemia, a rare but serious condition that can occur with excessive use.

Pharmacokinetics

Benzocaine is poorly soluble in water, which limits its systemic absorption when applied topically. It is rapidly absorbed through the skin, and its effects are localized. The half-life and metabolism details are not extensively documented, but the drug is primarily metabolized in the liver. Clearance from the system generally occurs within a short time frame, correlating with its brief duration of action.

Adverse effects

  • Methemoglobinemia
  • Allergic reactions
  • Local irritation
  • Skin rash

Precautions

  • Use with caution in patients with a history of methemoglobinemia
  • Not for use on large areas of damaged skin or mucous membranes
  • Avoid contact with eyes

Pregnancy

Benzocaine should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus. Consult a healthcare professional.

Breast-feeding

Benzocaine is generally considered safe for use during breastfeeding, but caution is advised. Consult a healthcare professional for specific recommendations.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Formulations

  • Topical cream
  • Topical gel
  • Topical ointment
  • Lozenges

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: benzocaine

PubChem CID 2337

Molecular formula: C9H11NO2

Mechanism of action

Benzocaine diffuses into nerve cells where it binds to sodium channels, preventing the channels from opening, and blocking the influx of sodium ions. Nerve cells unable to allow sodium into cells cannot depolarize and conduct nerve impulses. Benzocaine reversibly stabilizes the neuronal membrane with decreases its permeability to sodium ions. Depolarization of the neuronal membrane is inhibited thereby blocking the initiation and conduction of nerve impulses.

Pharmacodynamics

Benzocaine is indicated for use as a topical anesthetic. It has a duration of action of approximately 10 minutes and a wide therapeutic window. Patients should be counselled regarding the risks of methemoglobinemia.

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.